191 related articles for article (PubMed ID: 31707106)
1. Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids.
Kamble SH; Sharma A; King TI; Berthold EC; León F; Meyer PKL; Kanumuri SRR; McMahon LR; McCurdy CR; Avery BA
Toxicol Lett; 2020 Feb; 319():148-154. PubMed ID: 31707106
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes.
Pang NH; Xu RA; Chen LG; Chen Z; Hu GX; Zhang BW
Toxicol In Vitro; 2024 Mar; 95():105739. PubMed ID: 38042355
[TBL] [Abstract][Full Text] [Related]
3. Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of
Kamble SH; Sharma A; King TI; León F; McCurdy CR; Avery BA
Xenobiotica; 2019 Nov; 49(11):1279-1288. PubMed ID: 30547698
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V
Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427
[TBL] [Abstract][Full Text] [Related]
5.
Zhang C; Li Y; Yin C; Zheng J; Liu G
Pharm Biol; 2021 Dec; 59(1):935-940. PubMed ID: 35294326
[TBL] [Abstract][Full Text] [Related]
6.
Xu S; Zhang F; Chen D; Su K; Zhang L; Jiang R
Pharm Biol; 2020 Dec; 58(1):308-313. PubMed ID: 32285742
[No Abstract] [Full Text] [Related]
7. Anemarsaponin BII inhibits the activity of CYP3A4, 2D6, and 2E1 with human liver microsomes.
Wang M; Jiang W; Zhou J; Xue X; Yin C
Pharm Biol; 2020 Dec; 58(1):1064-1069. PubMed ID: 33103940
[TBL] [Abstract][Full Text] [Related]
8.
Li M; Liu X; Wang Y; Ju X
Xenobiotica; 2020 Oct; 50(10):1202-1207. PubMed ID: 32338127
[TBL] [Abstract][Full Text] [Related]
9.
Li Y; Qin J; Wu H; Xu Y; Zhang L; Su K; Cui Y; Wang H
Pharm Biol; 2020 Dec; 58(1):695-700. PubMed ID: 32673137
[TBL] [Abstract][Full Text] [Related]
10.
Zhang N; Liu J; Chen Z; Dou W
Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
[No Abstract] [Full Text] [Related]
11. An in vitro evaluation of kratom (Mitragyna speciosa) on the catalytic activity of carboxylesterase 1 (CES1).
Melchert PW; Zhang Q; Mukhopadhyay S; Kanumuri SRR; McCurdy CR; Markowitz JS
Chem Biol Interact; 2023 Oct; 384():110715. PubMed ID: 37716419
[TBL] [Abstract][Full Text] [Related]
12. Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations.
Tanna RS; Tian DD; Cech NB; Oberlies NH; Rettie AE; Thummel KE; Paine MF
J Pharmacol Exp Ther; 2021 Jan; 376(1):64-73. PubMed ID: 33093187
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of inhibitory effects of caffeic acid and quercetin on human liver cytochrome p450 activities.
Rastogi H; Jana S
Phytother Res; 2014 Dec; 28(12):1873-8. PubMed ID: 25196644
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human cytochrome P450 enzymes by licochalcone A, a naturally occurring constituent of licorice.
He W; Wu JJ; Ning J; Hou J; Xin H; He YQ; Ge GB; Xu W
Toxicol In Vitro; 2015 Oct; 29(7):1569-76. PubMed ID: 26100226
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory mechanisms of celastrol on human liver cytochrome P450 1A2, 2C19, 2D6, 2E1 and 3A4.
Jin C; He X; Zhang F; He L; Chen J; Wang L; An L; Fan Y
Xenobiotica; 2015; 45(7):571-7. PubMed ID: 25811791
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2E1 and CYP3A4 by extracts and alkaloids of Gelsemium elegans roots.
Wang Y; Wu S; Chen Z; Zhang H; Zhao W
J Ethnopharmacol; 2015 May; 166():66-73. PubMed ID: 25764964
[TBL] [Abstract][Full Text] [Related]
17. Effect of tubeimoside I on the activity of cytochrome P450 enzymes in human liver microsomes.
Wang R; Zheng K; Liu Y; Ji S; Tang Y; Wang J; Jiang R
Xenobiotica; 2024 Feb; 54(2):57-63. PubMed ID: 38166553
[TBL] [Abstract][Full Text] [Related]
18. In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6.
Ko JW; Desta Z; Soukhova NV; Tracy T; Flockhart DA
Br J Clin Pharmacol; 2000 Apr; 49(4):343-51. PubMed ID: 10759690
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of Huanglian [Rhizoma coptidis (L.)] and its six active alkaloids on six cytochrome P450 isoforms in human liver microsomes.
Han YL; Yu HL; Li D; Meng XL; Zhou ZY; Yu Q; Zhang XY; Wang FJ; Guo C
Phytother Res; 2011 Nov; 25(11):1660-5. PubMed ID: 21425377
[TBL] [Abstract][Full Text] [Related]
20.
Zhang J; Li C; Zhang J; Zhang F
Xenobiotica; 2019 Oct; 49(10):1127-1132. PubMed ID: 29676195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
